Letter to the Editor: Can the Seasonal Influenza Vaccine for 2019/2020 Have Cross Reactivity With Some of the Sars-Cov-2 Proteins?

Letter to the Editor: Can the Seasonal Influenza Vaccine for 2019/2020 Have Cross Reactivity With Some of the Sars-Cov-2 Proteins? Publisher Pubmed

Zandi M^{1, 2} ; Behboudi E³ ; Soltani S^{1, 2}

Show Affiliations

1. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
2. Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran

Source: International Journal of Infectious Diseases Published:2021

Abstract

[No abstract available]

Related Docs

1. Complement Inhibition: A Possible Therapeutic Approach in the Fight Against Covid-19, Reviews in Medical Virology (2022)

2. Role of Glycoprotein Hemagglutinin-Esterase in Covid-19 Pathophysiology?, Stem Cell Reviews and Reports (2021)

3. Comment on Alfassam Et Al. Development of a Colorimetric Tool for Sars-Cov-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. Pharmaceutics 2021, 13, 502, Pharmaceutics (2022)

Style	Citing Format
MLA	Zandi M, Behboudi E, Soltani S. "Letter to the Editor: Can the Seasonal Influenza Vaccine for 2019/2020 Have Cross Reactivity With Some of the Sars-Cov-2 Proteins?." International Journal of Infectious Diseases, vol. 110, no. , 2021, pp. 235-236.
APA	Zandi M, Behboudi E, Soltani S (2021). Letter to the Editor: Can the Seasonal Influenza Vaccine for 2019/2020 Have Cross Reactivity With Some of the Sars-Cov-2 Proteins?. International Journal of Infectious Diseases, 110(), 235-236.
Chicago	Zandi M, Behboudi E, Soltani S. "Letter to the Editor: Can the Seasonal Influenza Vaccine for 2019/2020 Have Cross Reactivity With Some of the Sars-Cov-2 Proteins?." International Journal of Infectious Diseases 110, no. (2021): 235-236.
Harvard	Zandi M, Behboudi E, Soltani S (2021) 'Letter to the Editor: Can the Seasonal Influenza Vaccine for 2019/2020 Have Cross Reactivity With Some of the Sars-Cov-2 Proteins?', International Journal of Infectious Diseases, 110(), pp. 235-236.
Vancouver	Zandi M, Behboudi E, Soltani S. Letter to the Editor: Can the Seasonal Influenza Vaccine for 2019/2020 Have Cross Reactivity With Some of the Sars-Cov-2 Proteins?. International Journal of Infectious Diseases. 2021;110():235-236.
BibTex	@article{ author = {Zandi M and Behboudi E and Soltani S}, title = {Letter to the Editor: Can the Seasonal Influenza Vaccine for 2019/2020 Have Cross Reactivity With Some of the Sars-Cov-2 Proteins?}, journal = {International Journal of Infectious Diseases}, volume = {110}, number = {}, pages = {235-236}, year = {2021} }
RIS	TY - JOUR AU - Zandi M AU - Behboudi E AU - Soltani S TI - Letter to the Editor: Can the Seasonal Influenza Vaccine for 2019/2020 Have Cross Reactivity With Some of the Sars-Cov-2 Proteins? JO - International Journal of Infectious Diseases VL - 110 IS - SP - 235 EP - 236 PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract